Partilhar
Informação da revista
Editorial
What does device-based hemodynamic optimization bring to clinical practice in cardiac resynchronization therapy?
Mário Martins Oliveira
Rev Port Cardiol. 2015;34:511-3
Open access
Original articles
Percutaneous treatment of mitral valve regurgitation: Initial experience with the MitraClip device
Duarte Cacela, António Fiarresga, Luísa Branco, Ana Galrinho, Pedro Rio, Mafalda Selas, Rui Ferreira
Rev Port Cardiol. 2015;34:515-24
Open access
Original Articles
Editorial comment
Introduction of percutaneous treatment for mitral regurgitation in Portugal
Eduardo Infante de Oliveira
Rev Port Cardiol. 2015;34:525-7
Open access
Permanent pacemaker implantation after aortic valve replacement: Long-term dependency or rhythm recovery?
Vânia Ribeiro, Raquel Mota Garcia, Cecília Frutuoso, Filipa Melão, Marta Pereira, Paulo Pinho, Maria Júlia Maciel
Rev Port Cardiol. 2015;34:529-33
Open access
Applicability of the Zwolle risk score for safe early discharge after primary percutaneous coronary intervention in ST-segment elevation myocardial infarction
António Tralhão, António Miguel Ferreira, Sérgio Madeira, Miguel Borges Santos, Mariana Castro, Ingrid Rosário, Marisa Trabulo, Carlos Aguiar, ... Miguel Mendes
Rev Port Cardiol. 2015;34:535-41
Open access
Autonomic activity and biomarker behavior in supine position and after passive postural stress in different orthostatic intolerance syndromes
João Freitas, Elsa Azevedo, Rosa Santos, Maria Júlia Maciel, Francisco Rocha-Gonçalves
Rev Port Cardiol. 2015;34:543-9
Open access
Short original article
M-mode apical systolic excursion: A new and simple method to evaluate global left ventricular longitudinal strain
José Amado, Fabián Islas, Islas Leopoldo Pérez de Isla, Jose Juan Gómez de Diego, Alberto de Agustín, Miguel Angel García-Fernandez
Rev Port Cardiol. 2015;34:551-4
Open access
Case report
Endovascular management of IVC syndrome after IVC filter placement
Konstantinos Marmagkiolis, Vasili Lendel, Mehmet Cilingiroglu
Rev Port Cardiol. 2015;34:555.e1-4
Open access
What do we know about carbon monoxide poisoning and cardiac compromise? Treatment and prognosis
Rosa Cardiga, Margarida Proença, Carolina Carvalho, Luís Costa, Arturo Botella, Filipa Marques, Carolina Paulino, António Carvalho, Cândida Fonseca
Rev Port Cardiol. 2015;34:557.e1-5
Open access
Dyspnea in a nonagenarian: The usual suspects, an unexpected culprit
Sérgio Madeira, Luís Raposo, Raquel David, Alexandre Marques, José Andrade Gomes, Nuno Cardim, Rui Anjos
Rev Port Cardiol. 2015;34:559.e1-6
Open access
Loculated cardiac hematoma causing hemodynamic compromise after cardiac surgery
Andreia Fernandes, Miryan Cassandra, Carlos Pinto, Catarina Oliveira, Manuel Antunes, Lino Gonçalves
Rev Port Cardiol. 2015;34:561.e1-3
Open access
Image in cardiology
Left to right and right to left
Anne Delgado, António Tralhão, Diogo Cavaco, Pedro Adragão
Rev Port Cardiol. 2015;34:563-4
Open access
Letters to the editor
Management of prosthetic valve thrombosis in pregnancy
Macit Kalçık, Mustafa Ozan Gürsoy, Sabahattin Gündüz, Mehmet Özkan
Rev Port Cardiol. 2015;34:565-6
Open access
Reply to the Letter to the Editor entitled “Management of prosthetic valve thrombosis in pregnancy”
Goncalo Cardoso
Rev Port Cardiol. 2015;34:567
Open access
Low-dose intravenous tissue-type plasminogen activator for prosthetic valve thrombosis is better than standard dose streptokinase
Murat Biteker, Özcan Başaran, Nesrin Filiz Başaran, Funda Sungur Biteker
Rev Port Cardiol. 2015;34:569
Open access
Reply to the Letter to the Editor entitled “Low-dose intravenous tissue-type plasminogen activator for prosthetic valve thrombosis is better than standard dose streptokinase”
Gonçalo Cardoso
Rev Port Cardiol. 2015;34:571
Open access
Recommended article of the month
Comment on “Long-term durability of bioprosthetic aortic valves: implications from 12,569 implants”
Paulo Pinho
Rev Port Cardiol. 2015;34:573-4
Open access
Conteúdo especial sobre COVID-19
- High prevalence of cardiovascular disease and risk factors among type 2 diabetes patients followed in a hospital setting in Portugal
- Clinical outcomes of percutaneous coronary intervention in chronic total occlusion in patients with type 2 diabetes mellitus
- Percutaneous coronary intervention in chronic total occlusions: Should it be avoided in type 2 diabetic patients?
- RAAS inhibitors in COVID-19: Not all are created equal. Telmisartan is the one
Publicar em
Revista Portuguesa de Cardiologia
A revista pertence ao Committee on Publication Ethics (COPE) www.publicationethics.org e adere aos seus princípios e procedimentos.